Subscribe to Money Morning get daily headlines subscribe now! Money Morning Private Briefing today's private briefing Access Your Profit Alerts

Drug Stocks

Article Index

Best Stocks to Buy Now: A Money Morning Weekly Recap

Best stocks to buy for the week ending Nov. 15, 2013: The markets continue to shatter records. The Dow Jones Industrial Average logged a sixth week of gains last week, closing at 15,961.70, and opened this week by topping 16,000 for the first time in history. And the S&P 500 Index hit 1,800 on Monday, […]

To continue reading, please click here...

Drug Stocks to Buy: New Statin Guidelines Are a Shot in the Arm for These Generics

They account for 264 million prescriptions annually in the U.S. alone, and $35 billion in annual global sales. Now doctors say these drugs could help treat an entirely different ailment, which affects hundreds of millions of people worldwide. That means sales are about to skyrocket.

And just two drug companies will reap the lion's share of the profits...

Drug Stocks a Good Buy Now as Pharma M&A Hits $50 Billion

Drug maker Shire has announced it will buy ViroPharma for $4.2 billion. This comes on the heels of Amgen's $10.4 billion offer for Onyx Pharmaceuticals in August and Perrigo's acquisition of Elan Corp. in July for $8.6 billion. Those are just a few of the dozens of pharma deals this year that have enriched shareholders. The good news? This is only the beginning.

You, too, can profit from this "feeding frenzy"...

4 Drug Stocks to Buy Now to Capitalize on Emerging Market Growth

Overall, this sector has healthy global sales of $959 billion and is expected to grow those sales at a rate of 4.5% a year. But in emerging markets, sales in this sector will grow at three times that rate. And on top of that, another development will make these markets even more lucrative.

We've identified the handful of companies best-positioned to take advantage of this...

Is This Drug the Key to an Alzheimer's Cure?

Among the top 10 causes of death by disease, Alzheimer's is the only one that cannot be cured, treated, or slowed down. But that may be about to change - and a vaccine could soon be at hand.